Company Description
Gemphire Therapeutics Inc. today announced expanded utility for gemcabene with compelling preclinical data results demonstrating proof of concept efficacy in a well-established animal model of nonalcoholic steatohepatitis (NASH).[Source: MarketWatch]
Company Website: https://www.gencoshipping.com